Intellectual Property India Publishes Patent Application for 'Pegylated Moxifloxacin Prodrugs For Sustained Release And Macrophage-Targeted Tuberculosis Treatment' Filed by Dr. D. Y. Patil Institute Of Pharmaceutical Sciences And Research; School Of Pharmacy And Research; and Dr. Ritesh P. Bhole

MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202521118777 A) filed by Dr. D. Y. Patil Institute Of Pharmaceutical Sciences And Research; School Of Pharmacy And Research; and Dr. Ritesh P. Bhole, Pune, Maharashtra, on Nov. 28, 2025, for 'pegylated moxifloxacin prodrugs for sustained release and macrophage-targeted tuberculosis treatment.'

Inventor(s) include Dr. Ritesh P. Bhole; Dr. H. S. Kapare; Dr. Sonali D. Labhade; and Mr. Pawan N. Karwa.

The application for the patent was published on Jan. 9, under issue no. 02/2026.

According to the abstract released by the Intellectual Property India: "The invention relates to polymer-drug conjugates comprising polyethylene glycol (PEG) covalently linked ...